BNB Plus Corp. (BNBX) 株式分析
金融サービスBNB Plus Corp.
$0.40
+$0.02 (+5.40%)
最終更新日: 2026年5月26日
株価推移
価格データがありません
分析
企業概要
BNB Plus Corp. operates within the financial services sector, specifically focusing on the asset management industry, where it provides specialized digital asset treasury services and real-time data tracking for treasury performance and market indicators. The company leverages its subsidiaries to develop and commercialize technologies designed for the production and detection of deoxyribonucleic acid (DNA) and ribonucleic acid, thereby diversifying its operational scope beyond traditional financial management. As a mid-sized entity in its niche, the firm employs 26 staff members and maintains a market capitalization of $3.50M, reflecting a relatively small market presence compared to large-cap financial institutions. With annual revenue of $1.83M, the company's financial scale indicates a micro-cap status, suggesting limited liquidity and a position in the lower tier of the asset management hierarchy where specialized technology and niche services drive valuation rather than broad-scale fee generation.
財務健全性
The company reported a trailing twelve-month revenue of $1.83M alongside a net income of $-70,157,456, a significant disparity that reveals a highly volatile cost structure or substantial non-operating expenses eroding profitability despite positive revenue generation. This negative net income contrasts sharply with an EBITDA of $-28,339,856, indicating that while operating cash flows before interest and taxes are negative, the severity of the loss is amplified by interest expenses or other financing costs when calculating net income. Free cash flow stands at $-17,404,216, which implies that the company is burning cash at a significant rate, thereby limiting its financial flexibility to fund operations, pursue new growth initiatives, or weather market downturns without external capital injection. Margin analysis highlights a gross margin of 29.9%, which suggests a moderate ability to cover direct production costs, yet this is overshadowed by an operating margin of -3248.8% and a profit margin of 0.0%, figures that indicate severe operational inefficiencies or one-time charges impacting the bottom line. On the balance sheet, the company holds $2.45M in cash against a debt obligation of $48,861, resulting in a debt-to-equity ratio of 0.27, which characterizes the capital structure as conservative and low-leveraged despite the operational losses. The current ratio of 2.32 demonstrates a robust short-term liquidity position, suggesting the company possesses more than double the current assets required to meet its short-term liabilities. However, return metrics show a return on equity of -199.1% and a return on assets of -98.0%, revealing that management is currently generating negative returns on both shareholder capital and the total asset base, signaling a need for strategic pivots to restore capital efficiency.
バリュエーション評価
Valuation metrics for BNB Plus Corp. present a complex picture, with a trailing P/E ratio of 0.00 and a forward P/E listed as N/A, implying that the absence of positive earnings prevents the use of traditional multiples and suggests high uncertainty regarding future earnings trajectory. The price-to-book ratio is 0.16, which indicates that the market values the company at a fraction of its book value, suggesting either significant undervaluation, poor asset quality, or a market penalty for the company's negative earnings and operational risks. Alternative valuation measures such as the price-to-sales ratio of 1.91 and an EV/EBITDA of -0.02 further illustrate the difficulty in applying standard comparative valuation models to a firm with negative earnings and cash flows. The stock's trading range over the past year spans from a 52-week low of $0.60 to a high of $24.30, creating a wide volatility band where the current price position must be evaluated relative to this extensive historical range to understand recent market sentiment. The beta coefficient of 0.70 suggests that the stock's price volatility is lower than the broader market, indicating that the asset may be less sensitive to general market fluctuations, although this lower beta does not mitigate the fundamental risks associated with the company's negative financial performance.
Growth & Income
Revenue growth year-over-year has declined by 35.0%, while earnings growth is N/A due to the lack of prior year positive earnings for comparison, implying that the company is currently in a contractionary phase rather than an expansionary growth cycle. The company does not pay dividends, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, which means that instead of returning cash to shareholders, the firm retains earnings—though currently negative—to fund its ongoing operations and research and development activities. The overall growth and income profile is characterized by negative revenue momentum and a complete absence of income distribution, positioning the stock as a high-risk speculative vehicle rather than an income-generating investment.
同業他社比較
BNB Plus Corp. (BNBX) は資産運用業界で事業を展開しています。時価総額による最も近い同業他社との比較は以下の通りです:
| 企業名 | ティッカー | 時価総額 | PER |
|---|---|---|---|
| BNB Plus Corp. | BNBX | $2.88M | 0.0 |
| BlackRock, Inc. | BLK | $167.25B | 27.1 |
| Blackstone Inc. | BX | $144.37B | 30.3 |
| Brookfield Corporation | BN.TO | $142.06B | 89.6 |
資産運用業界の平均PERは28.6倍です。BNB Plus Corp.のPERは0.0です。
この分析はAIによって生成されたものであり、情報提供のみを目的としています。投資アドバイスではありません。データは遅延または不正確な場合があります。投資判断を行う前に、必ずご自身で調査を行い、資格を持つファイナンシャルアドバイザーにご相談ください。
関連する資産運用銘柄
BlackRock, Inc.
$167.25B
BXBlackstone Inc.
$144.37B
BN.TOBrookfield Corporation
$142.06B
BAM.TOBrookfield Asset Management Ltd.
$108.42B
BNBrookfield Corporation
$102.79B
KKRKKR & Co. Inc.
$88.57B
金融サービスの人気銘柄
Berkshire Hathaway Inc.
$1.38T
BRK-BBerkshire Hathaway Inc.
$1.04T
BRK-ABerkshire Hathaway Inc.
$1.04T
JPMJPMorgan Chase & Co.
$821.91B
VVisa Inc.
$620.88B
BNB Plus Corp.について
BNB Plus Corp. provides digital asset treasury services. The company offers real-time data tracking of treasury performance and market indicators. The company, through its subsidiaries, also develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) in the Americas, Europe, Asia, and internationally. The company engages in the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and nucleic acid production solutions for the biopharmaceutical and diagnostics industries, including LineaDNA, LineaRNAP, and LineaIVT, as well as the development and sale of a proprietary RNAP for use in the production of mRNA therapeutics. BNB Plus Corp. was formerly known as Applied DNA Sciences, Inc. and changed its name to BNB Plus Corp. in November 2025. The company was founded in 1983 and is based in Stony Brook, New York.
企業説明は英語で表示されています。
ウェブサイトを見る →